ask="20.60"
ask_size="200"
average_daily_volume="201239"
bid="17.65"
bid_size="2100"
book_value="7.04"
change="-0.10"
change_from_200_day_moving_average="4.32"
change_from_50_day_moving_average="0.73"
change_from_52_week_high="-4.99"
change_From_52_week_low="8.15"
change_in_percent="-0.49%"
close="20.50"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.06"
ebitda="-79.91M"
eps_estimate_current_year="-3.17"
eps_estimate_next_quarter="-0.92"
eps_estimate_next_year="-3.33"
ex_dividend_date="N/A"
float_shares="18669000"
high="20.85"
high_52_weeks="25.49"
last_trade_date="1/19/2017"
last_trade_price="20.50"
last_trade_size="5788"
last_trade_time="4:00pm"
low="20.25"
low_52_weeks="12.35"
market_capitalization="584.56M"
moving_average_200_day="16.18"
moving_average_50_day="19.77"
name="Revance Therapeutics
Inc."
notes="N/A"
one_year_target_price="36.60"
open="20.50"
pe_ratio="N/A"
peg_ratio="-0.60"
percent_change_from_200_day_moving_average="+26.70%"
percent_change_from_50_day_moving_average="+3.69%"
percent_change_from_52_week_high="-19.58%"
percent_change_from_52_week_low="+65.99%"
previous_close="20.60"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.93"
price_per_sales="1958.03"
revenue="300000.00"
shares_outstanding="28515000"
short_ratio="22.54"
stock_exchange="NGM"
symbol="RVNC"
volume="88130"
weeks_range_52="12.35 - 25.49"
